Latest Pressure Biosciences (PBIO) Headlines Pr
Post# of 1354
Posted On: 03/13/2014 12:20:12 PM
Latest Pressure Biosciences (PBIO) Headlines
Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA"). The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom.
TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
Pressure BioSciences Introducing New Technology for Its Pressure Cycling Platform
PRWeb - Thu Jan 16, 5:14AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) record sales in the third-quarter have given the company a bright future. Analysts are even more optimistic about 2014 because the company is going to introduce a breakthrough technology for use in its pressure cycling platform that uses an HT system.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call at 4:30 p.m. EST on Thursday, December 12, 2013
PR Newswire - Wed Dec 11, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), will host an investor call for PBI on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Board Chairman Jeffrey N. Peterson will provide an update on the Company, including a review of the achievements of 2013 and stated goals for 2014, via a webcast with an accompanying PowerPoint presentation.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call
Thomson Reuters ONE - Mon Dec 09, 8:24AM CST
SAN FRANCISCO - December 9, 2013 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will host a conference call for Pressure BioSciences, Inc. ("Pressure BioSciences") (OTCQB: PBIO) on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Chairman Jeffrey N. Peterson will provide comments on the Company with an accompanying presentation.
Pressure BioSciences, Inc. -- (PBIO) Featured in Flaherty Financial News Newsletter #40
Marketwire - Mon Nov 25, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) led off snapshots of four presentations featured in the November 22, 2013 issue of Flaherty Financial News Newsletter. PBIO's record third quarter and year-to-date 2013 sales, guidance for a strong fourth quarter and expectations to reach breakeven in two years were discussed. However, the highlight was "a core technology breakthrough." CEO Ric Schumacher believes their new high throughput Barocycler instruments will be ready for release by mid-June 2014, and that it is a "game changer." The breakthrough will automate its current highly manual test tube sample preparation system and will allow it to be directly integrated with thousands of downstream instruments now in use by scientists in an estimated 80,000 laboratories worldwide.
Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
PR Newswire - Mon Nov 18, 12:20PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, the Company's President and CEO, presented a business and financial update on the Company at the November 12th SeeThruEquity Investor Conference in New York City.
Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
PR Newswire - Thu Nov 07, 12:33PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced record financial results for the three and nine-month periods ended September 30, 2013 and provided a business update.
Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
PR Newswire - Wed Nov 06, 6:47AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Pressure BioSciences, Inc.
Marketwire - Mon Nov 04, 9:48AM CST
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO) on Pressure BioSciences, Inc. (OTCQB: PBIO). The full 76-page report is available on Crystal Research Associates' website at www.crystalra.com.
SeeThruEquity, LLC Initiates Coverage on Pressure BioSciences, Inc.
PR Newswire - Thu Oct 24, 10:51AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that SeeThruEquity, LLC, an independent investment research and corporate access firm, has initiated equity research coverage on the Company. The research report is available for viewing and downloading at www.seethruequity.com.
OTC Daily Alert Stock Watch - Pressure BioSciences, Inc (OTC: PBIO)
WorldStockWire - Wed Oct 16, 1:00AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
OTC Daily Alert Stock Watch - Pressure BioSciences, Inc. (OTCQB: PBIO)
WorldStockWire - Fri Sep 06, 10:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Kevin Pollack of Pressure BioSciences, Inc. (PBIO)-OTC Markets bought Shares of PBIO
M2 - Mon Aug 26, 9:03AM CDT
Reported by InsiderCow.com at 2013-08-23 14:51:06 ET
Pressure BioSciences, Inc. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 15, 9:06AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three and six-month periods ended June 30, 2013 and provided a business update.
Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
PR Newswire - Tue Aug 13, 10:06AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Second Quarter 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Merriman Capital Initiates on Pressure BioSciences with Speculative Buy
Thomson Reuters ONE - Thu Aug 08, 10:10AM CDT
SAN FRANCISCO - August 8, 2013 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it has initiated equity research coverage of Pressure BioSciences Incorporated ("the Company") (OTCQB: PBIO) at a Speculative Buy and a $0.70 price target.
Novel Use of Pressure BioSciences' Patented PCT Platform Offers New Insights into Protein Structure and Function, New Tool for Biomarker Discovery and Rational Drug Design
PR Newswire - Thu Aug 01, 7:16AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that data supporting important advantages of PBI's powerful and enabling Pressure Cycling Technology ("PCT") platform were presented at the 27th Annual Symposium of the Protein Society held July 20-23, 2013 in Boston, Massachusetts.
Pressure BioSciences, Inc. to Present at the OneMedForum New York 2013 Emerging Company Finance Conference
ACCESSWIRE - Tue Jun 25, 1:46PM CDT
Presentation Will Highlight Company's Two Recent PCT Technology Breakthroughs
Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA"). The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom.
TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
Pressure BioSciences Introducing New Technology for Its Pressure Cycling Platform
PRWeb - Thu Jan 16, 5:14AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) record sales in the third-quarter have given the company a bright future. Analysts are even more optimistic about 2014 because the company is going to introduce a breakthrough technology for use in its pressure cycling platform that uses an HT system.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call at 4:30 p.m. EST on Thursday, December 12, 2013
PR Newswire - Wed Dec 11, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), will host an investor call for PBI on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Board Chairman Jeffrey N. Peterson will provide an update on the Company, including a review of the achievements of 2013 and stated goals for 2014, via a webcast with an accompanying PowerPoint presentation.
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call
Thomson Reuters ONE - Mon Dec 09, 8:24AM CST
SAN FRANCISCO - December 9, 2013 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will host a conference call for Pressure BioSciences, Inc. ("Pressure BioSciences") (OTCQB: PBIO) on Thursday, December 12, 2013 at 4:30 p.m. EST. Pressure BioSciences CEO Richard T. Schumacher and Chairman Jeffrey N. Peterson will provide comments on the Company with an accompanying presentation.
Pressure BioSciences, Inc. -- (PBIO) Featured in Flaherty Financial News Newsletter #40
Marketwire - Mon Nov 25, 8:02AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) led off snapshots of four presentations featured in the November 22, 2013 issue of Flaherty Financial News Newsletter. PBIO's record third quarter and year-to-date 2013 sales, guidance for a strong fourth quarter and expectations to reach breakeven in two years were discussed. However, the highlight was "a core technology breakthrough." CEO Ric Schumacher believes their new high throughput Barocycler instruments will be ready for release by mid-June 2014, and that it is a "game changer." The breakthrough will automate its current highly manual test tube sample preparation system and will allow it to be directly integrated with thousands of downstream instruments now in use by scientists in an estimated 80,000 laboratories worldwide.
Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
PR Newswire - Mon Nov 18, 12:20PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, the Company's President and CEO, presented a business and financial update on the Company at the November 12th SeeThruEquity Investor Conference in New York City.
Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
PR Newswire - Thu Nov 07, 12:33PM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced record financial results for the three and nine-month periods ended September 30, 2013 and provided a business update.
Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
PR Newswire - Wed Nov 06, 6:47AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Pressure BioSciences, Inc.
Marketwire - Mon Nov 04, 9:48AM CST
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO) on Pressure BioSciences, Inc. (OTCQB: PBIO). The full 76-page report is available on Crystal Research Associates' website at www.crystalra.com.
SeeThruEquity, LLC Initiates Coverage on Pressure BioSciences, Inc.
PR Newswire - Thu Oct 24, 10:51AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that SeeThruEquity, LLC, an independent investment research and corporate access firm, has initiated equity research coverage on the Company. The research report is available for viewing and downloading at www.seethruequity.com.
OTC Daily Alert Stock Watch - Pressure BioSciences, Inc (OTC: PBIO)
WorldStockWire - Wed Oct 16, 1:00AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
OTC Daily Alert Stock Watch - Pressure BioSciences, Inc. (OTCQB: PBIO)
WorldStockWire - Fri Sep 06, 10:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Kevin Pollack of Pressure BioSciences, Inc. (PBIO)-OTC Markets bought Shares of PBIO
M2 - Mon Aug 26, 9:03AM CDT
Reported by InsiderCow.com at 2013-08-23 14:51:06 ET
Pressure BioSciences, Inc. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 15, 9:06AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three and six-month periods ended June 30, 2013 and provided a business update.
Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
PR Newswire - Tue Aug 13, 10:06AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Second Quarter 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Merriman Capital Initiates on Pressure BioSciences with Speculative Buy
Thomson Reuters ONE - Thu Aug 08, 10:10AM CDT
SAN FRANCISCO - August 8, 2013 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it has initiated equity research coverage of Pressure BioSciences Incorporated ("the Company") (OTCQB: PBIO) at a Speculative Buy and a $0.70 price target.
Novel Use of Pressure BioSciences' Patented PCT Platform Offers New Insights into Protein Structure and Function, New Tool for Biomarker Discovery and Rational Drug Design
PR Newswire - Thu Aug 01, 7:16AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that data supporting important advantages of PBI's powerful and enabling Pressure Cycling Technology ("PCT") platform were presented at the 27th Annual Symposium of the Protein Society held July 20-23, 2013 in Boston, Massachusetts.
Pressure BioSciences, Inc. to Present at the OneMedForum New York 2013 Emerging Company Finance Conference
ACCESSWIRE - Tue Jun 25, 1:46PM CDT
Presentation Will Highlight Company's Two Recent PCT Technology Breakthroughs
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼